Search results for "Antivirals"
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
New cardiovascular indication approved for diabetes drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022
Recent articles look at COVID-19 risk by blood type, ethical lessons, prone positioning
People in Italy and Spain with type A blood had increased risk of severe COVID-19, and prone positioning increased oxygenation, studies found. The FDA changed its position on hydroxychloroquine and ACP reaffirmed its stance.
https://immattersacp.org/weekly/archives/2020/06/23/1.htm
23 Jun 2020
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
False positives on syphilis test after COVID-19 vaccination
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/02/false-positives-on-syphilis-test-after-covid-19-vaccination.htm
1 Feb 2022
HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk
Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016
Be proactive about managing hepatitis B
Reports and other guidance on both hepatitis B virus prevention and treatment all have reprised a common theme: Clearly vulnerable individuals are too often missed.
https://immattersacp.org/archives/2018/04/be-proactive-about-managing-hepatitis-b.htm
1 Apr 2018
Recent guidance offered on preparing to treat COVID-19
ACP has developed a new practice management resource on telehealth care in response to the novel coronavirus disease (COVID-19) and continues to press the U.S. government to do more to address the pandemic.
https://immattersacp.org/weekly/archives/2020/03/17/1.htm
17 Mar 2020
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
Managing diabetes meds more complicated in elderly patients
This issue covers topics including management of diabetes in the elderly, the public release of Medicare payments to physicians, and new approaches to antivirals as flu season begins.
https://immattersacp.org/archives/2014/10/editors.htm
1 Oct 2014